中国实用内科杂志2024，Vol.44Issue(1)：1-6,6.DOI:10.19538/j.nk2024010101
新疾病名称"代谢功能障碍相关脂肪性肝病"意义解析
Analysis of the significance of the new disease name"metabolic dysfunction-associate steatotic liver disease"
摘要
Abstract
About a quarter of the world's population now has nonalcoholic fatty liver disease(NAFLD).With increasing of the prevalence of NAFLD,the occurrence of fatty liver associated cirrhosis and hepatocellular carcinoma hadreplacedother cause become the first cause of liver transplantation.However,the term"NAFLD"was an exclusionary diagnosis and potentially stigmatizing language,the concept of"metabolic dysfunction-associate fatty liver disease(MAFLD)"was put up to instead NAFLD.The argue is continuing about the two nomenclatures,recently a new concept,steatotic liver disease was put forward and"MAFLD"was suggested to be substituted by"metabolic dysfunction-associate steatotic liver disease(MASLD)".Here we will introduce and compare the three nomenclature in order to help physicians to understand and utilize them better.关键词
非酒精性脂肪性肝病/代谢相关脂肪性肝病/代谢功能障碍相关脂肪变性肝病Key words
nonalcoholic fatty liver disease/metabolic dysfunction-associate fatty liver disease/metabolic dysfunction-associate steatotic liver disease分类
医药卫生引用本文复制引用
陈思彤,徐航飞,卫小蝶,赵锦涵,张洋,张晶..新疾病名称"代谢功能障碍相关脂肪性肝病"意义解析[J].中国实用内科杂志,2024,44(1):1-6,6.基金项目
首都卫生发展科研专项(2022-2Z-2187) （2022-2Z-2187）
北京市医院管理中心临床医学发展专项(YGLX202339) （YGLX202339）
